The S&P/ASX 200 (Index: ^AXJO) (ASX:XJO) is again trading sharply lower today as investors continue to worry about the uncertainty surrounding Trump and Brexit.
The benchmark index has lost around 0.55% with the biggest falls coming from the financial and healthcare sectors.
A number of shares have come under serious selling pressure today, including:
BT Investment Management Ltd (ASX: BTT)
BT is one of the biggest losers for the second day in a row as investors continue to worry about Brexit and the flow on effects to its UK-based operations. The fund manager also announced yesterday that its head of international operations would leave to invest with another asset management firm. The shares have lost more than 4% today and nearly 9% since the start of the year.
Bendigo and Adelaide Bank Ltd (ASX: BEN)
Shares of Bendigo and Adelaide Bank have fallen more than 4% today, despite no news from the company. Interestingly, the ASX's other regional bank, Bank of Queensland Limited (ASX: BOQ), is also significantly underperforming the sector today with a share price fall of more than 2.4%. Both banks have enjoyed quite solid gains over the past six months however, so I wouldn't be surprised if some investors are just locking in profits today.
ResMed Inc. (CHESS) (ASX: RMD)
Shares of ResMed have fallen 3.5% today, despite the absence of any news from the company. A number of other healthcare shares with exposure to the U.S. health system are also under pressure today as investors continue to worry about the changes Donald Trump could make to the system. The shares also haven't been helped by the Australian dollar, which climbed to a two-month high overnight.
Mantra Group Ltd (ASX: MTR)
Shares of Mantra have slumped 2.8% today, despite no notable news from the company. This is a very interesting move considering the latest tourism figures revealed inbound tourist numbers continued to trend strongly higher over the back end of 2016. As one of the premier accommodation providers across Australia, Mantra would be expected to be a key beneficiary of this trend. Unfortunately for shareholders, the shares continue to be impacted by weak investor sentiment and are now trading near their 52-week low of $2.87.
